Flow cytometry applications in detection and classification of leukemia/lymphoma

R H Widen1

  • 1Pathology Department, Tampa General Hospital.

The Journal of the Florida Medical Association
|December 1, 1992
PubMed

Insights

Flow cytometry, using monoclonal antibodies, is now a vital clinical tool for diagnosing leukemia. This technique accurately distinguishes cancerous cells from benign ones, improving patient care.

Area of Science:

  • Clinical immunology
  • Hematology
  • Medical technology

Background:

  • Flow cytometry has transitioned from a research tool to a clinical laboratory staple.
  • Advancements in monoclonal antibodies and user-friendly flow cytometers facilitate this shift.
  • Clinical applications include sensitive detection and differentiation of leukemias.

Purpose of the Study:

  • To present the application of immunophenotyping for leukemia/lymphoma diagnosis.
  • To explain the basic instrumentation of flow cytometry in a clinical context.
  • To illustrate the diagnostic utility of immunophenotyping through case reviews.

Main Methods:

  • Utilizing monoclonal antibodies targeting human leukocyte surface markers.
  • Employing advanced, user-friendly clinical flow cytometry instrumentation.
  • Applying immunophenotyping techniques for leukemia and lymphoma analysis.

Main Results:

  • Demonstrated the specific and sensitive detection of leukemia.
  • Showcased the differentiation of leukemia from benign lymphoproliferations.
  • Case reviews confirmed the utility in lineage assignment and diagnosis.

Conclusions:

  • Flow cytometry immunophenotyping is crucial for accurate leukemia/lymphoma diagnosis.
  • The technology significantly impacts patient care by enabling correct lineage assignment.
  • Immunophenotyping represents a key advancement in clinical hematology diagnostics.